Archford Capital Strategies LLC Grows Holdings in UnitedHealth Group (UNH)

Archford Capital Strategies LLC lifted its position in UnitedHealth Group (NYSE:UNH) by 48.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,725 shares of the healthcare conglomerate’s stock after buying an additional 560 shares during the quarter. Archford Capital Strategies LLC’s holdings in UnitedHealth Group were worth $380,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently modified their holdings of the company. Geode Capital Management LLC raised its stake in UnitedHealth Group by 4.1% during the 4th quarter. Geode Capital Management LLC now owns 9,969,166 shares of the healthcare conglomerate’s stock valued at $2,193,088,000 after purchasing an additional 395,090 shares during the last quarter. Alliancebernstein L.P. raised its stake in UnitedHealth Group by 1.3% during the 4th quarter. Alliancebernstein L.P. now owns 7,334,593 shares of the healthcare conglomerate’s stock valued at $1,616,984,000 after purchasing an additional 96,727 shares during the last quarter. Jennison Associates LLC raised its stake in UnitedHealth Group by 10.2% during the 4th quarter. Jennison Associates LLC now owns 6,107,513 shares of the healthcare conglomerate’s stock valued at $1,346,462,000 after purchasing an additional 565,536 shares during the last quarter. Legal & General Group Plc raised its stake in UnitedHealth Group by 1.3% during the 3rd quarter. Legal & General Group Plc now owns 5,153,894 shares of the healthcare conglomerate’s stock valued at $1,009,355,000 after purchasing an additional 68,196 shares during the last quarter. Finally, UBS Asset Management Americas Inc. raised its stake in UnitedHealth Group by 11.4% during the 4th quarter. UBS Asset Management Americas Inc. now owns 5,013,564 shares of the healthcare conglomerate’s stock valued at $1,105,290,000 after purchasing an additional 512,182 shares during the last quarter. Institutional investors and hedge funds own 87.11% of the company’s stock.

Several equities analysts recently commented on UNH shares. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 target price for the company in a research note on Saturday, January 20th. Credit Suisse Group upped their target price on shares of UnitedHealth Group from $252.00 to $260.00 and gave the company an “outperform” rating in a research note on Wednesday, January 17th. Cantor Fitzgerald reiterated a “buy” rating and set a $280.00 target price on shares of UnitedHealth Group in a research note on Thursday, March 8th. Morgan Stanley boosted their price target on shares of UnitedHealth Group from $275.00 to $277.00 and gave the company an “overweight” rating in a report on Wednesday, April 18th. Finally, Argus boosted their price target on shares of UnitedHealth Group to $270.00 and gave the company a “buy” rating in a report on Thursday, January 18th. Two equities research analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus target price of $253.70.

Shares of UNH traded up $2.22 during trading hours on Wednesday, hitting $241.72. The stock had a trading volume of 1,906,025 shares, compared to its average volume of 3,706,191. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.71 and a current ratio of 0.71. UnitedHealth Group has a 52 week low of $238.61 and a 52 week high of $240.48. The firm has a market cap of $233.42 billion, a price-to-earnings ratio of 24.00, a PEG ratio of 1.40 and a beta of 0.75.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 17th. The healthcare conglomerate reported $3.04 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.91 by $0.13. UnitedHealth Group had a net margin of 5.41% and a return on equity of 22.06%. The business had revenue of $55.19 billion for the quarter, compared to analyst estimates of $54.90 billion. During the same quarter in the prior year, the firm earned $2.37 EPS. The firm’s quarterly revenue was up 13.3% compared to the same quarter last year. sell-side analysts anticipate that UnitedHealth Group will post 12.61 EPS for the current fiscal year.

In related news, CEO Steven H. Nelson sold 14,233 shares of the company’s stock in a transaction dated Thursday, March 15th. The shares were sold at an average price of $230.22, for a total transaction of $3,276,721.26. Following the transaction, the chief executive officer now owns 18,219 shares in the company, valued at approximately $4,194,378.18. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Richard T. Burke sold 10,400 shares of the company’s stock in a transaction dated Thursday, March 1st. The stock was sold at an average price of $229.87, for a total transaction of $2,390,648.00. Following the transaction, the director now owns 1,781,657 shares in the company, valued at approximately $409,549,494.59. The disclosure for this sale can be found here. In the last quarter, insiders have sold 72,019 shares of company stock worth $16,550,733. 0.87% of the stock is owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply